CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,568,000 | +11.2% | 800,000 | +23.1% | 3.26% | +24.3% |
Q2 2023 | $21,203,000 | +0.4% | 650,000 | +8.3% | 2.62% | -38.3% |
Q1 2023 | $21,114,000 | +15.2% | 600,000 | +50.0% | 4.25% | +10.6% |
Q4 2022 | $18,328,000 | +8.1% | 400,000 | +14.3% | 3.85% | +16.8% |
Q3 2022 | $16,958,000 | -17.8% | 350,000 | -33.3% | 3.29% | -22.4% |
Q2 2022 | $20,627,000 | +19.2% | 525,000 | +11.7% | 4.24% | -5.8% |
Q1 2022 | $17,301,000 | +16.8% | 470,000 | +44.6% | 4.50% | +9.8% |
Q4 2021 | $14,814,000 | +27.5% | 325,000 | 0.0% | 4.10% | +22.8% |
Q3 2021 | $11,616,000 | -16.1% | 325,000 | -53.6% | 3.34% | -12.5% |
Q2 2021 | $13,853,000 | -14.9% | 700,000 | 0.0% | 3.81% | -18.0% |
Q1 2021 | $16,282,000 | +49.2% | 700,000 | +33.3% | 4.65% | +43.4% |
Q4 2020 | $10,910,000 | +152.0% | 525,000 | +162.5% | 3.24% | +145.1% |
Q3 2020 | $4,330,000 | -46.0% | 200,000 | -41.2% | 1.32% | -44.8% |
Q2 2020 | $8,014,000 | +112.4% | 340,000 | +6.2% | 2.40% | +44.4% |
Q1 2020 | $3,773,000 | – | 320,000 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 875,656 | $5,534,000 | 3.79% |
BVF INC/IL | 4,150,639 | $26,232,000 | 3.43% |
GREAT POINT PARTNERS LLC | 3,173,288 | $20,055,000 | 2.54% |
DAFNA Capital Management LLC | 185,826 | $1,174,000 | 0.58% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 90,783 | $574,000 | 0.53% |
Foresite Capital Management IV, LLC | 175,148 | $1,107,000 | 0.51% |
LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $16,735,000 | 0.25% |
WASATCH ADVISORS LP | 2,456,805 | $15,527,000 | 0.21% |
PINNACLE ASSOCIATES LTD | 592,778 | $3,746,000 | 0.10% |
South Dakota Investment Council | 895,316 | $7,238,000 | 0.08% |